Mutational Analysis of Putative Genetic Elements Required for Vmp Regulated Expression and Antigenic Variation by the Relapsing Fever Agent, Borrelia hermsii
回归热病原赫氏疏螺旋体 Vmp 调节表达和抗原变异所需的推定遗传元件的突变分析
基本信息
- 批准号:10188845
- 负责人:
- 金额:$ 19.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-24 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAnimalsAntigenic SwitchingAntigenic VariationAreaAttenuatedBlood specimenBorreliaCharacteristicsClinicalComplementDNADNA SequenceDiseaseElementsEventFeverFutureGene ConversionGene ExpressionGeneticGenetic RecombinationGenetic TranscriptionGoalsHeadacheHealthHumanImmune EvasionImmune responseImmunocompetentIndividualInfectionInterruptionInverted Repeat SequencesInvestigationKnowledgeLengthMediatingMembrane ProteinsMessenger RNAMissionMonitorMusMusculoskeletal PainMutationMutation AnalysisNauseaOutcomePathogenesisProcessPromoter RegionsProteinsPublic HealthPublishingQuantitative Reverse Transcriptase PCRRecurrenceRegulationRelapseRelapsing FeverResearchRoleSequence HomologySeriesStructureSymptomsSystemTechniquesTestingTick-Borne Relapsing FeverTimeTranscriptTranslationsUnited StatesUnited States National Institutes of HealthVariantWestern BlottingWorkbasecis acting elementdisabilitygenetic elementgenetic manipulationhuman pathogenmutantpathogenpromoterprotein expressionrelapsing fever borreliatelomeretime intervaltool
项目摘要
Summary
Borrelia hermsii is a causative agent of tick-borne relapsing fever, which is a bacterial illness
characterized by severe recurrent febrile episodes. The undulating fever that is characteristic of the disease is a
direct result of Vmp antigenic variation and sequential immune evasion by the pathogen. Recent work in our lab
has provided evidence that a region upstream from the vmp locus may be involved in the regulation of Vmp
expression, and that a mutant clone deficient in vmp expression was unable to undergo vmp recombination.
Additionally, a mutant clone lacking an inverted DNA repeat residing in a downstream homology region did not
exhibit Vmp antigenic variation. Despite these advancements, the exact identity and role of cis-acting genetic
elements in vmp regulated expression and recombination remain unknown. The objective of our application will
be to identify cis-acting DNA regions of the vmp locus that are important for vmp regulated expression and
recombination. Based on published and preliminary findings, our central hypothesis is that the tandem inverted
repeat sequences are involved in the regulated expression of vmp, and that vmp transcription is required for the
gene conversion process. Additionally, we hypothesize that it is the secondary hairpin structure of the DHS-
resident inverted repeat sequence that is essential for vmp recombination. The rationale for addressing these
knowledge gaps is that the resulting outcomes will lay the groundwork for additional investigations aimed at
disrupting the antigenic variation system that underpins the pathogenesis of disease. Thus, the proposed
research is relevant to that part of NIH’s mission that pertains to developing fundamental knowledge that will
potentially help to reduce the burdens of human illness and disability.
Our central hypothesis will be tested by pursuing three specific aims: 1) Determine the role of the tandem
inverted repeat sequences for regulated expression of vmp, 2) Determine the importance of vmp expression for
gene conversion, and 3) Establish the requirement of the DHS-resident inverted repeat structure for vmp
recombination. Under the first aim, individual inverted DNA repeats will be deleted using our telomere-mediated
deletion/complementation technique. Transcription and translation of vmp from mutant clones or an isogenic wild
type control will be determined via qRT-PCR and Western blot analysis, respectively. Additionally, mRNA
transcript levels will be quantified from blood samples obtained from infected mice at varying time intervals and
compared to those from the wild type control. Under the second aim, mutations will be generated within the vmp
promoter region and used to infect mice to look for a loss of antigenic switching compared to a wild type control.
In the third aim, the inverted repeat within the DHS will be interrupted or DNA sequence altered while retaining
the overall sequence length. Antigenic variation compared to the wild type control will be monitored after infecting
immunocompetent mice. Overall, our experimental approach will allow for direct mutational analysis of putative
cis-acting elements to gain further understanding of this immune evasion system of B. hermsii.
总结
赫氏疏螺旋体是蜱传回归热的病原体,这是一种细菌性疾病
以严重的反复发热为特征。这种疾病的特征是起伏的发热,
Vmp抗原变异和病原体的连续免疫逃避的直接结果。我们实验室最近的工作
已经提供了证据表明,从vmp基因座上游的区域可能参与调节Vmp
vmp表达缺陷的突变克隆不能进行vmp重组。
此外,缺乏位于下游同源区的反向DNA重复序列的突变克隆不
表现出Vmp抗原变异。尽管取得了这些进展,顺式作用基因的确切身份和作用仍不清楚。
在VMP调节的表达和重组中的元件仍然未知。我们申请的目的是
鉴定vmp基因座的顺式作用DNA区域,其对于vmp调节表达是重要的,
重组根据已发表的和初步的研究结果,我们的中心假设是,
重复序列参与vmp的调节表达,vmp转录是vmp基因表达所必需的。
基因转换过程此外,我们假设它是DHS的二级发夹结构-
对于vmp重组必需的常驻反向重复序列。解决这些问题的基本原理
知识差距是,由此产生的结果将为旨在
破坏支持疾病发病机制的抗原变异系统。因此,拟议的
研究与国家卫生研究院的使命有关,即发展基础知识,
可能有助于减轻人类疾病和残疾的负担。
我们的中心假设将通过追求三个具体目标进行测试:1)确定串联的作用
2)确定vmp表达对于调节vmp表达的重要性,
基因转换,以及3)建立vmp的DHS驻留反向重复结构的要求
重组在第一个目标下,将使用我们的端粒介导的
缺失/互补技术。来自突变克隆或同基因野生型的vmp的转录和翻译
将分别通过qRT-PCR和Western印迹分析确定类型对照。此外,mRNA
在不同的时间间隔从感染小鼠获得的血液样品中定量转录物水平,
与来自野生型对照的那些相比。在第二个目标下,突变将在vmp内产生
启动子区,并用于感染小鼠以寻找与野生型对照相比抗原转换的损失。
在第三个目标中,DHS内的反向重复序列将被中断或DNA序列改变,同时保留
整个序列长度。感染后,将监测与野生型对照相比的抗原变异
免疫活性小鼠。总的来说,我们的实验方法将允许直接突变分析推定的
顺式作用元件以获得对B的这种免疫逃避系统的进一步理解。赫姆斯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Troy Michael Bankhead其他文献
Troy Michael Bankhead的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Troy Michael Bankhead', 18)}}的其他基金
Mutational Analysis of Putative Genetic Elements Required for Vmp Regulated Expression and Antigenic Variation by the Relapsing Fever Agent, Borrelia hermsii
回归热病原赫氏疏螺旋体 Vmp 调节表达和抗原变异所需的推定遗传元件的突变分析
- 批准号:
10473671 - 财政年份:2021
- 资助金额:
$ 19.13万 - 项目类别:
Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete
对莱姆病螺旋体蜱定殖重要的 lp17 编码遗传因子的探索性研究
- 批准号:
10373101 - 财政年份:2021
- 资助金额:
$ 19.13万 - 项目类别:
Functional and Mechanistic Studies of the VlsE-mediated Immune Avoidance System in the Lyme Disease Spirochete
莱姆病螺旋体 VlsE 介导的免疫回避系统的功能和机制研究
- 批准号:
10371053 - 财政年份:2021
- 资助金额:
$ 19.13万 - 项目类别:
Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete
对莱姆病螺旋体蜱定殖重要的 lp17 编码遗传因子的探索性研究
- 批准号:
10188065 - 财政年份:2021
- 资助金额:
$ 19.13万 - 项目类别:
Mechanistic and Functional Analysis of a Putative Regulatory Factor in the Lyme Disease Spirochete
莱姆病螺旋体假定调节因子的机制和功能分析
- 批准号:
10316195 - 财政年份:2020
- 资助金额:
$ 19.13万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
8836954 - 财政年份:2014
- 资助金额:
$ 19.13万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
8611524 - 财政年份:2014
- 资助金额:
$ 19.13万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
9247117 - 财政年份:2014
- 资助金额:
$ 19.13万 - 项目类别:
Mutational analysis of the vlp/vsp antigenic variation system of the relapsing fe
复发性FEVLP/VSP抗原变异系统的突变分析
- 批准号:
8501363 - 财政年份:2012
- 资助金额:
$ 19.13万 - 项目类别:
Mutational analysis of the vlp/vsp antigenic variation system of the relapsing fe
复发性FEVLP/VSP抗原变异系统的突变分析
- 批准号:
8354084 - 财政年份:2012
- 资助金额:
$ 19.13万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 19.13万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 19.13万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 19.13万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 19.13万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 19.13万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别: